SENIOR CARE PHARMACY COALITION for SENIOR CARE PHARMACY COALITION
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices. H.R. 5031 / S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act. H.R. 8800 / S. 4784 National Defense Authorization Act for Fiscal Year 2027 (FY2027 NDAA). H.R. 3164 / S. 2426 Ensuring Community Access to Pharmacist Services Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ESME GRANT GREWAL | — |
| SHARA SIEGEL | Food and Drug Administration, Public Health Advisor (March 2024-June 2025) |
Medicare/Medicaid MMM
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices. H.R. 5031 / S. 3159 Preserving Patient Access to Long-Term Care Pharmacies Act. H.R. 8800 / S. 4784 National Defense Authorization Act for Fiscal Year 2027 (FY2027 NDAA). H.R. 3164 / S. 2426 Ensuring Community Access to Pharmacist Services Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ESME GRANT GREWAL | — |
| SHARA SIEGEL | Food and Drug Administration, Public Health Advisor (March 2024-June 2025) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.